The Patient-Centered Outcomes Research Institute is taking action to boost the number of head-to-head comparative effectiveness trials it funds after a review of applications selected for funding during its first three cycles found a relatively low number of direct head-to-head comparisons.
“It’s pretty clear that PCORI needs to do something to increase in its portfolio the numbers of genuine primary comparative...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?